Obermeyer Wood Investment Counsel Lllp reduced its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.6% in the third quarter, according to its most recent filing with the SEC. The fund owned 189,245 shares of the healthcare conglomerate’s stock after selling 4,983 shares during the period. UnitedHealth Group makes up 3.2% of Obermeyer Wood Investment Counsel Lllp’s investment portfolio, making the stock its 12th biggest position. Obermeyer Wood Investment Counsel Lllp’s holdings in UnitedHealth Group were worth $37,064,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Blue Chip Partners Inc. bought a new stake in UnitedHealth Group in the second quarter worth $110,000. Bruderman Asset Management LLC bought a new stake in UnitedHealth Group in the second quarter worth $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. lifted its stake in UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after purchasing an additional 520 shares during the last quarter. BDO Wealth Advisors LLC bought a new stake in UnitedHealth Group in the second quarter worth $121,000. Finally, Acrospire Investment Management LLC lifted its stake in UnitedHealth Group by 130.7% in the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after purchasing an additional 400 shares during the last quarter. 86.01% of the stock is owned by institutional investors.
Several analysts have weighed in on UNH shares. Goldman Sachs Group started coverage on shares of UnitedHealth Group in a research note on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 price target for the company. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Morgan Stanley boosted their price target on shares of UnitedHealth Group from $215.00 to $235.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 18th. ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. Finally, Leerink Swann reissued a “buy” rating and issued a $240.00 price target (up from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Three research analysts have rated the stock with a hold rating and twenty-five have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $229.54.
UnitedHealth Group Inc (UNH) opened at $228.64 on Friday. UnitedHealth Group Inc has a one year low of $156.09 and a one year high of $231.77. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. The company has a market cap of $218,418.13, a PE ratio of 25.35, a PEG ratio of 1.53 and a beta of 0.66.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The company had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. During the same quarter in the previous year, the company earned $2.17 earnings per share. UnitedHealth Group’s quarterly revenue was up 8.7% on a year-over-year basis. sell-side analysts predict that UnitedHealth Group Inc will post 9.99 EPS for the current year.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total value of $1,250,536.00. Following the sale, the director now owns 61,137 shares in the company, valued at $13,652,503.47. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Thomas E. Roos sold 975 shares of the company’s stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $205.47, for a total transaction of $200,333.25. Following the completion of the sale, the insider now owns 24,630 shares in the company, valued at approximately $5,060,726.10. The disclosure for this sale can be found here. Insiders have sold 34,630 shares of company stock worth $7,669,416 in the last quarter. 0.89% of the stock is owned by corporate insiders.
ILLEGAL ACTIVITY NOTICE: This news story was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another domain, it was copied illegally and republished in violation of international copyright and trademark legislation. The legal version of this news story can be read at https://www.dispatchtribunal.com/2018/01/13/unitedhealth-group-inc-unh-shares-sold-by-obermeyer-wood-investment-counsel-lllp.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.